Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In July - Cibus (NASDAQ:CBUS), Bellerophon Therapeutics (NASDAQ:BLPH)Benzinga • 07/05/23
Panbela Announces PACES S0820 Phase III Trial Passes Pre-Planned Futility AnalysisGlobeNewsWire • 06/28/23
Panbela Announces Poster Presentation at the Endocrine Society Meeting: Polyamine Inhibition and β-Cell Preservation in Recent Onset Type 1 DiabetesGlobeNewsWire • 06/26/23
Panbela Announces Sponsored Research Agreement to Evaluate Polyamine Metabolic Inhibitor Therapy in Combination with CAR-T Cell TherapyGlobeNewsWire • 06/13/23
Panbela Announces Poster Presentation at Immunology of Diabetes Society Meeting: Evaluating the Potential of CPP-1X (Eflornithine) in Recent Onset Type 1 DiabetesGlobeNewsWire • 06/01/23
Panbela Announces Clinical Trial with Moffitt Cancer Center for Phase I/II Program in STK11 Mutant Non-Small Cell Lung CancerGlobeNewsWire • 05/22/23
Panbela Announces Poster Presentation at American Association for Cancer Research: Evaluating the potential of spermine analogue ivospemin (SBP-101) in combination with chemotherapy in ovarian cancerGlobeNewsWire • 04/19/23
First Patient Enrolled in JDRF-Funded Phase II Trial of CPP-1X-T for Recent Onset Type I Diabetes, Led by Indiana University School of MedicineGlobeNewsWire • 04/12/23
Panbela Regains Worldwide Rights to Develop and Commercialize FlynpoviTM in Patients with Familial Adenomatous Polyposis (FAP)GlobeNewsWire • 04/11/23
Acceptance of CPP-1X (DFMO) Abstract for Poster Presentation at Immunology of Diabetes Society MeetingGlobeNewsWire • 04/10/23
Acceptance of CPP-1X (DFMO) Abstract for Poster Presentation at Endocrine Society MeetingGlobeNewsWire • 04/06/23
Panbela Announces New Research Agreement with Johns Hopkins University School of MedicineGlobeNewsWire • 04/03/23
Panbela Announces Issuance of New Patent in Japan; Patent is for Claims of a Novel Process for the Production of SBP-101GlobeNewsWire • 03/22/23